Hepatitis C reinfection in former and active injecting drug users in Belgium

BACKGROUND: There is currently no systematic screening for hepatitis C (HCV) reinfection in people who inject drugs (PWID) after treatment in Belgium. However, in a recent meta-analysis, the overall HCV reinfection rate was 5.9/100 person-years (PY) among PWID. Accordingly, this study was undertaken...

Descripción completa

Detalles Bibliográficos
Autores principales: Busschots, Dana, Bielen, Rob, Koc, Özgür M., Heyens, Leen, Verrando, Rita, de Galocsy, Chantal, Van Steenkiste, Christophe, Nevens, Frederik, Midgard, Håvard, Dalgard, Olav, Robaeys, Geert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507240/
https://www.ncbi.nlm.nih.gov/pubmed/34641896
http://dx.doi.org/10.1186/s12954-021-00552-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507240/
https://www.ncbi.nlm.nih.gov/pubmed/34641896
http://dx.doi.org/10.1186/s12954-021-00552-x

Ejemplares similares